Market Access

HTAnalyze supports organizations in critical market access, pricing, and value creation projects, combining clinical evidence, HEOR (Health, Employee Risk, and Operations), budget impact, and RWE (Reliability-Based Evidence) into robust and traceable deliverables. We operate extensively in key decision-making pathways in Brazil, including Conitec, ANS, and CMED, and possess the technical capacity to handle international demands.

Market Access – Brazil

Conitec (SUS) Submissions

We develop submissions to Conitec with methodological rigor and complete deliverables, integrating clinical evidence, economic evaluation, and budgetary impact for decisions within the SUS (Brazilian Public Health System).

Useful information and links

Public consultations: analysis and technical contributions

We support companies and institutions in building consistent contributions and responses, with a clear narrative, scientific backing, and strategic positioning.

Learn More

Preliminary assessment of submission feasibility

We mapped the scenario and maturity of the dossier to guide the decision: submit, supplement evidence, or revise strategy.

Learn More

ANS Submissions (List)

We structure dossiers and analyses for submissions to the ANS (Brazilian National Agency for Supplementary Health), with methodological rigor, clarity in the value proposition, and alignment with regulatory deadlines.

Useful information and links

CMED Price Dossier

We structure CMED price dossiers with technical and documentary consistency, integrating references, comparators, and justifications in accordance with regulations.

Learn More

Support for submission and technical defense.

We offer comprehensive support for technical submission and defense, including technical forms such as FormRol, presentation preparation, strategic alignment, and support in conducting meetings with decision-making committees.

Learn More